Condition

Clinical trials for GLP - 1

Active public studies that list GLP - 1 as a condition.

8active studies

3recruiting now

4countries represented

2largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 2

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Obesity in Children, Bone StrengthCondition

GLP-1 receptor agonist, Lifestyle interventionTreatment

United States1 locations

University of VirginiaSponsor

Updated 2026-04-17 · NCT06903923See eligibility →

Recruiting nowPhase 2

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults

Obesity Prevention, Sarcopenia in ElderlyCondition

TirzepatideTreatment

United States1 locations

The University of Texas Health Science Center at San AntonioSponsor

Updated 2026-04-15 · NCT06811324See eligibility →

Recruiting nowPhase 4

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

Bipolar I Disorder, Bipolar II DisorderCondition

Group Therapy Program, semaglutideTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-03-11 · NCT07213466See eligibility →

Opening soonNot applicable

A Study on Ubiquinol on Fatigue and Muscle Strength in Healthy Adults Taking GLP-1 Agonists

Obesity & Overweight, GLP - 1Condition

Ubiquinol 100 MG Oral Capsule, PlaceboTreatment

United Kingdom1 locations

StudySetGoSponsor

Updated 2026-09-01 · NCT07789106See eligibility →

Opening soonPhase 4

GLP-1s in Hip and Knee Arthroplasty

Arthritis, Obesity & OverweightCondition

GLP-1 Receptor Agonists + Behavioral modification, Behavioral + placeboTreatment

Canada1 locations

Nova Scotia Health AuthoritySponsor

Updated 2026-08-10 · NCT07755085See eligibility →

Opening soonNot applicable

Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation

Weight Loss, GLP - 1Condition

Weight Loss Maintenance Program (Foundational), Mom's MealsTreatment

United States1 locations

University of Alabama at BirminghamSponsor

Updated 2026-06-26 · NCT07535892See eligibility →

Opening soonPhase 4

Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1

GLP - 1, Obesity & OverweightCondition

Semaglutide, Dietary CounselingTreatment

United States1 locations

William Marsh Rice UniversitySponsor

Updated 2026-04-28 · NCT07554417See eligibility →

Invitation onlyNot applicable

Multivitamin Impact on Micronutrient Status in GLP-1 Users: A Randomized Trial

Weight Loss, Nutritional DeficienciesCondition

Multivitamin Supplementation, PlaceboTreatment

Netherlands2 locations

Erasmus Medical CenterSponsor

Updated 2025-11-19 · NCT07234916See eligibility →

Related conditions

Obesity1,102 Obesity & Overweight220 Overweight205 Overweight and Obesity130 Type 2 Diabetes108 Hypertension107

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.